Atsuhiro Yasuhara

Cornell University — United States

Medicine · Health Sciences

19h-index2.9kcitations42works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(21), Influenza Virus Research Studies(17), COVID-19 Clinical Research Studies(15), Respiratory viral infections research(14), Viral gastroenteritis research and epidemiology(7)

Publications42 total

Characterization and immunogenicity of nanoparticle vaccines based on Clade 2 and Clade 3 sarbecovirus S2 proteins
npj Vaccines·2025Open Access
Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2
The Journal of Experimental Medicine·2025· 2 citedOpen Access
In Vivo Evolution of Monoclonal Antibody CR3022 to Achieve Cross-Neutralization of SARS-CoV-2 and Implications for Vaccine Strategies Against SARS-Related Viruses
2025Open Access
A single residue change only differing by an atomic group can drive imprinting to influenza
2025Open Access
Multivalent S2 subunit vaccines provide broad protection against Clade 1 sarbecoviruses in female mice
Nature Communications·2025· 14 citedOpen Access
Dysbiosis of gut microbiota in COVID-19 is associated with intestinal DNA phage dynamics of lysogenic and lytic infection
Microbiology Spectrum·2024Open Access
Multivalent S2-subunit Vaccines Provide Broad Protection Against Clade 1 Sarbecoviruses
2024Open Access
Seroprevalence of SARS-CoV-2 antibodies in dogs and cats during the early and mid-pandemic periods in Japan
One Health·2023· 8 citedOpen Access
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
Journal of Clinical Investigation·2023· 14 citedOpen Access
Ferret model to mimic the sequential exposure of humans to historical H3N2 influenza viruses
Vaccine·2022· 15 citedOpen Access
A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases
Nature Communications·2022· 53 citedOpen Access
Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020–March 2022
Emerging infectious diseases·2022· 5 citedOpen Access
Age-stratified seroprevalence of antibodies against SARS-CoV-2 in the pre- and post-vaccination era, February 2020–March 2022, Japan
2022Open Access
Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters
Nature Microbiology·2022· 37 citedOpen Access
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
Nature·2022· 288 citedOpen Access
Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan
Internal Medicine·2022· 3 citedOpen Access
Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization
Microbiology Spectrum·2022· 87 citedOpen Access
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
2022· 41 citedOpen Access
ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury
Nature Communications·2021· 54 citedOpen Access
ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury
Research Square (Research Square)·2021· 1 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Yoshihiro Kawaoka(38), Seiya Yamayoshi(26), Mutsumi Ito(20), Kiyoko Iwatsuki‐Horimoto(19), Maki Kiso(16), Masaki Imai(13), Yuko Sakai‐Tagawa(13), Peter Halfmann(10), Moe Okuda(10), S. Yamada(9), Michiko Koga(9), Eisuke Adachi(9), Michiko Ujie(8), Jurika Murakami(8), Hiroshi Yotsuyanagi(8), S. Chiba(7), Ryuta Uraki(7), Makoto Saito(7), Keiko Mitamura(7), Patrick C. Wilson(7)